Terms: = Pancreatic cancer AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L
72 results:
1. Development of Potent Dual BET/HDAC Inhibitors via Pharmacophore Merging and Structure-Guided Optimization.
Bauer N; Balourdas DI; Schneider JR; Zhang X; Berger LM; Berger BT; Schwalm MP; Klopp NA; Siveke JT; Knapp S; Joerger AC
ACS Chem Biol; 2024 Feb; 19(2):266-279. PubMed ID: 38291964
[TBL] [Abstract] [Full Text] [Related]
2. Pan-cancer analysis reveals the characteristics and roles of tooth agenesis mutant genes.
Liu Y; Yang J; Li X; Chen S; Zhu C; Shi Y; Dang S; Zhang W; Li W
Medicine (Baltimore); 2023 Dec; 102(50):e36001. PubMed ID: 38115305
[TBL] [Abstract] [Full Text] [Related]
3. Dual-branch hybrid encoding embedded network for histopathology image classification.
Li M; Hu Z; Qiu S; Zhou C; Weng J; Dong Q; Sheng X; Ren N; Zhou M
Phys Med Biol; 2023 Sep; 68(19):. PubMed ID: 37647919
[No Abstract] [Full Text] [Related]
4. Analysis of a new therapeutic target and construction of a prognostic model for breast cancer based on ferroptosis genes.
Li Q; Liu H; Jin Y; Yu Y; Wang Y; Wu D; Guo Y; Xi L; Ye D; Pan Y; Zhang X; Li J
Comput Biol Med; 2023 Oct; 165():107370. PubMed ID: 37643511
[TBL] [Abstract] [Full Text] [Related]
5. Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST.
de Mestier L; Resche-Rigon M; Dromain C; Lamarca A; La Salvia A; de Baker L; Fehrenbach U; Pusceddu S; Colao A; Borbath I; de Haas R; Rinzivillo M; Zerbi A; Funicelli L; de Herder WW; Selberherr A; Wagner AD; Manoharan P; De Cima A; Lybaert W; Jann H; Prinzi N; Faggiano A; Annet L; Walenkamp A; Panzuto F; Pedicini V; Pitoni MG; Siebenhuener A; Mayerhoefer ME; Ruszniewski P; Vullierme MP
J Neuroendocrinol; 2023 Jun; 35(6):e13311. PubMed ID: 37345276
[TBL] [Abstract] [Full Text] [Related]
6. Two machine learning-based nomogram to predict risk and prognostic factors for liver metastasis from pancreatic neuroendocrine tumors: a multicenter study.
Li J; Huang L; Liao C; Liu G; Tian Y; Chen S
BMC Cancer; 2023 Jun; 23(1):529. PubMed ID: 37296397
[TBL] [Abstract] [Full Text] [Related]
7. The High Presence of HCMV pp71 Proteins, Correlate with p63 Expression in pancreatic cancer Tumor Tissue.
Abdul-Razzaq LN; Ali Jassim MM; Mahmood MM
Asian Pac J Cancer Prev; 2023 Apr; 24(4):1443-1447. PubMed ID: 37116169
[TBL] [Abstract] [Full Text] [Related]
8. Gonadal vein leiomyosarcoma, from clinical practice to a literature review: surgical, oncological and histopathologic correlation.
Imbriani GC; Guarro G; Di Somma MD; Sarno I; Ardito R; Botte M; Fabrizio T; Scala D
Acta Biomed; 2023 Apr; 94(S1):e2023129. PubMed ID: 37057464
[TBL] [Abstract] [Full Text] [Related]
9. Cytologic features of metastatic epithelioid uterine leiomyosarcoma to the pancreas.
Hardy NL; Canakis A; Staats PN; Darwin P; Legesse T
Diagn Cytopathol; 2023 Jan; 51(1):E21-E24. PubMed ID: 36082519
[TBL] [Abstract] [Full Text] [Related]
10. Integrative transcriptomic analysis identifies a novel gene signature to predict prognosis of pancreatic cancer in different subtypes.
Li CY; Rajapakshe KI; Maitra A
Pancreatology; 2022 Nov; 22(7):965-972. PubMed ID: 36008214
[TBL] [Abstract] [Full Text] [Related]
11. Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancer.
Datta J; Bianchi A; De Castro Silva I; Deshpande NU; Cao LL; Mehra S; Singh S; Rafie C; Sun X; Chen X; Dai X; Colaprico A; Sharma P; Dosch AR; Pillai A; Hosein PJ; Nagathihalli NS; Komanduri KV; Wilson JM; Ban Y; Merchant NB
Oncogene; 2022 Jul; 41(28):3640-3654. PubMed ID: 35701533
[TBL] [Abstract] [Full Text] [Related]
12. An exceptionally rare case of metastatic high-grade urothelial carcinoma of the renal pelvis to the pancreas diagnosed on endoscopic ultrasound-guided fine-needle aspiration: A diagnostic challenge.
Koyuncuer A; Sayar S; Zemheri IE; Özdil K; Özçelik M
Diagn Cytopathol; 2022 Oct; 50(10):E295-E300. PubMed ID: 35656642
[TBL] [Abstract] [Full Text] [Related]
13. APR-246-The Mutant TP53 Reactivator-Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of pancreatic cancer Cells.
McCubrey JA; Abrams SL; Steelman LS; Cocco L; Ratti S; Martelli AM; Lombardi P; Gizak A; Duda P
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204775
[TBL] [Abstract] [Full Text] [Related]
14. NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network.
Mammarella E; Zampieri C; Panatta E; Melino G; Amelio I
Biol Direct; 2021 Aug; 16(1):11. PubMed ID: 34348766
[TBL] [Abstract] [Full Text] [Related]
15. Liver Metastasis-Directed Ablative Radiotherapy in pancreatic cancer Offers Prolonged Time Off Systemic Therapy in Selected Patients: Data From a Multi-institutional Retrospective Study.
Lee G; Kim DW; Oladeru OT; Niemierko A; Gergelis KR; Haddock MG; Toesca DAS; Koong AJ; Owen D; Weekes C; Hong TS; Chang DT; Hallemeier CL; Wo JY
Pancreas; 2021 May-Jun 01; 50(5):736-743. PubMed ID: 34016893
[TBL] [Abstract] [Full Text] [Related]
16. Primary squamous cell carcinoma of the pancreas with a large pseudocyst of the pancreas as the first manifestation: a rare case report and literature review.
Qiu X; Meng Y; Lu M; Tian C; Wang M; Zhang J
BMC Gastroenterol; 2021 May; 21(1):208. PubMed ID: 33964875
[TBL] [Abstract] [Full Text] [Related]
17. Transcriptome profiling reveals liver metastasis-associated genes in pancreatic ductal adenocarcinoma.
Yu Y; Wang Z; Mo DH; Wang Z; Li G
Math Biosci Eng; 2021 Feb; 18(2):1708-1721. PubMed ID: 33757206
[TBL] [Abstract] [Full Text] [Related]
18. World Survey on Minimally Invasive Donor Hepatectomy: A Global Snapshot of Current Practices in 2370 Cases.
Rotellar F; Ciria R; Wakabayashi G; Suh KS; Cherqui D;
Transplantation; 2022 Jan; 106(1):96-105. PubMed ID: 33586922
[TBL] [Abstract] [Full Text] [Related]
19. The inhibition effect of natural food supplement active ingredients on tp63 carcinoma cell.
Gökalp F
Med Oncol; 2020 Nov; 37(12):120. PubMed ID: 33222005
[TBL] [Abstract] [Full Text] [Related]
20. Establishment and characterization of NCC-lms2-C1-a novel patient-derived cancer cell line of leiomyosarcoma.
Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2021 Jan; 34(1):279-288. PubMed ID: 33001379
[TBL] [Abstract] [Full Text] [Related]
[Next]
